rs1559509
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_016133.4(INSIG2):c.244+1551G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.246 in 151,996 control chromosomes in the GnomAD database, including 4,740 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.25 ( 4740 hom., cov: 32)
Consequence
INSIG2
NM_016133.4 intron
NM_016133.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.154
Publications
13 publications found
Genes affected
INSIG2 (HGNC:20452): (insulin induced gene 2) The protein encoded by this gene is highly similar to the protein product encoded by gene INSIG1. Both INSIG1 protein and this protein are endoplasmic reticulum proteins that block the processing of sterol regulatory element binding proteins (SREBPs) by binding to SREBP cleavage-activating protein (SCAP), and thus prevent SCAP from escorting SREBPs to the Golgi. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.272 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| INSIG2 | NM_016133.4 | c.244+1551G>A | intron_variant | Intron 2 of 5 | ENST00000245787.9 | NP_057217.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| INSIG2 | ENST00000245787.9 | c.244+1551G>A | intron_variant | Intron 2 of 5 | 1 | NM_016133.4 | ENSP00000245787.4 |
Frequencies
GnomAD3 genomes AF: 0.246 AC: 37362AN: 151878Hom.: 4736 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
37362
AN:
151878
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.246 AC: 37387AN: 151996Hom.: 4740 Cov.: 32 AF XY: 0.244 AC XY: 18143AN XY: 74310 show subpopulations
GnomAD4 genome
AF:
AC:
37387
AN:
151996
Hom.:
Cov.:
32
AF XY:
AC XY:
18143
AN XY:
74310
show subpopulations
African (AFR)
AF:
AC:
11430
AN:
41434
American (AMR)
AF:
AC:
2893
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
830
AN:
3464
East Asian (EAS)
AF:
AC:
583
AN:
5162
South Asian (SAS)
AF:
AC:
1224
AN:
4806
European-Finnish (FIN)
AF:
AC:
1963
AN:
10568
Middle Eastern (MID)
AF:
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
AC:
17625
AN:
67952
Other (OTH)
AF:
AC:
495
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1418
2837
4255
5674
7092
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
404
808
1212
1616
2020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
689
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.